Impact of obesity on clinical outcomes and the treatment effect of catheter ablation in atrial fibrillation: insights from CABANA
Europace · 01.10.2026 · 28 (10)
DOI: 10.1093/europace/euag293 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Europace, online erschienen am 29.10.2026. Verfasst von Jonas Erzeel und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Ziekenhuis Oost-Limburg A.V., Genk, Belgium. Hauptthemen laut MEDLINE: Atrial Fibrillation, Catheter Ablation, Obesity, Anti-Arrhythmia Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific Research Flanders, Belgian American Educational Foundation, Frans Van de Werf Fund.
Abstract (Originalsprache)
Aims
Obesity and atrial fibrillation (AF) are global epidemics, often co-existing and compounding cardiovascular risk. While catheter ablation has emerged as an effective strategy for rhythm control in symptomatic AF, it remains unclear whether obesity modifies its benefit. This post hoc analysis of the CABANA trial investigates the influence of baseline obesity on clinical outcomes after catheter ablation vs. drug therapy in AF patients. Methods and results A total of 2170 CABANA participants with available body mass index (BMI) were included. Obesity was defined by BMI ≥ 30 kg/m2, and Class II obesity by BMI ≥ 35 kg/m2. Adverse outcomes, AF recurrence, and functional status were analysed using Cox, mixed-effects, and generalized estimating equation models, assessing treatment-by-obesity interactions. Obese patients exhibited higher comorbidity burden, worse baseline functional status, and more persistent AF compared to non-obese counterparts. Higher BMI was associated with increased cardiovascular hospitalization and a higher New York Heart Association functional class. Catheter ablation significantly reduced the risk of AF recurrence and improved symptom burden and functional capacity, irrespective of obesity status. No significant interaction was found between BMI and treatment effect on the primary composite endpoint of cardiovascular hospitalization or all-cause mortality. However, patients with Class II obesity or higher had worse absolute outcomes despite similar relative benefits from ablation.
Conclusion
While obesity is associated with worse baseline status and outcomes, it was not shown to significantly alter the relative effectiveness of AF ablation compared to drug therapy. These findings support a multifaceted approach integrating rhythm control with upstream interventions targeting obesity-related atrial remodelling and comorbidity management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Ziekenhuis Oost-Limburg A.V., Genk, Belgium.
- UHasselt, Faculty of Medicine and Life Sciences, Agoralaan, 3590 Diepenbeek, Belgium / LCRC(-MHU).
- Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, 9500 Euclid Avenue, Desk J3-4, Cleveland, OH 44195, USA.
ORCID-Profile: Jonas Erzeel, Sebastiaan Dhont, Marnicq van Es, Michiel De Wever, Evelyne Meekers, Hugo Van Herendael, Dieter Nuyens, Maximo Rivero-Ayerza, Laurent Pison, Wilfried Mullens, Wai Hong Wilson Tang, Pieter Martens
Förderung
- Scientific Research Flanders
- Belgian American Educational Foundation
- Frans Van de Werf Fund
- Biologic Specimen and Data Repository Information Coordinating Center
- BioLINCC
- NIH HHS
- National Institutes of Health
Zitieren
APA
Erzeel, J., Dhont, S., van Es, M., De Wever, M., Meekers, E., Van Herendael, H., Nuyens, D., Rivero-Ayerza, M., Pison, L., Mullens, W., Tang, W. H. W., & Martens, P. (2026). Impact of obesity on clinical outcomes and the treatment effect of catheter ablation in atrial fibrillation: insights from CABANA. Europace, 28(10). https://doi.org/10.1093/europace/euag293
Vancouver
Erzeel J, Dhont S, van Es M, De Wever M, Meekers E, Van Herendael H, et al. Impact of obesity on clinical outcomes and the treatment effect of catheter ablation in atrial fibrillation: insights from CABANA. Europace. 2026;28(10). doi:10.1093/europace/euag293
BibTeX
@article{Erzeel2026,
author = {Erzeel, Jonas and Dhont, Sebastiaan and van Es, Marnicq and De Wever, Michiel and Meekers, Evelyne and Van Herendael, Hugo and Nuyens, Dieter and Rivero-Ayerza, Maximo and Pison, Laurent and Mullens, Wilfried and Tang, Wai Hong Wilson and Martens, Pieter},
title = {Impact of obesity on clinical outcomes and the treatment effect of catheter ablation in atrial fibrillation: insights from CABANA},
journal = {Europace},
year = {2026},
volume = {28},
number = {10},
doi = {10.1093/europace/euag293}
}
EUVIMED